Administering immunosuppressive drugs by feeding tube in kidney transplant recipients: Practical guide for nephrologists.

IF 1 4区 医学 Q3 UROLOGY & NEPHROLOGY Clinical nephrology Pub Date : 2025-06-01 DOI:10.5414/CN111661
Kai Ming Chow, Simon Wai Yin So
{"title":"Administering immunosuppressive drugs by feeding tube in kidney transplant recipients: Practical guide for nephrologists.","authors":"Kai Ming Chow, Simon Wai Yin So","doi":"10.5414/CN111661","DOIUrl":null,"url":null,"abstract":"<p><p>Kidney transplant recipients require immunosuppressive maintenance therapy to avoid acute rejection and the loss of the kidney graft. Most of the drugs, except belatacept, are solid oral medications which pose difficulty for patients who need enteral feeding tube. Appropriate drug delivery through enteral feeding tubes requires consideration of the tube placement site, drug formulation and compatibility. Occupational safety of handling drugs should also be addressed. We reviewed the available literature to ensure comprehensive inclusion of evidence to guide enteral feeding tube administration of immunosuppressive therapy for transplant recipients. An in-depth framework is suggested that prioritizes patients' oral administration of immunosuppressive medication, followed by intravenous administration as short-term measures, and enteral feeding tube administration only when this is the sole route feasible. A practical guide is hereby provided when the transplant team has to resort to enteral feeding tube for drug administration.\u2029.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":"414-420"},"PeriodicalIF":1.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5414/CN111661","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Kidney transplant recipients require immunosuppressive maintenance therapy to avoid acute rejection and the loss of the kidney graft. Most of the drugs, except belatacept, are solid oral medications which pose difficulty for patients who need enteral feeding tube. Appropriate drug delivery through enteral feeding tubes requires consideration of the tube placement site, drug formulation and compatibility. Occupational safety of handling drugs should also be addressed. We reviewed the available literature to ensure comprehensive inclusion of evidence to guide enteral feeding tube administration of immunosuppressive therapy for transplant recipients. An in-depth framework is suggested that prioritizes patients' oral administration of immunosuppressive medication, followed by intravenous administration as short-term measures, and enteral feeding tube administration only when this is the sole route feasible. A practical guide is hereby provided when the transplant team has to resort to enteral feeding tube for drug administration.
.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肾移植受者通过饲管给予免疫抑制药物:肾内科医生实用指南。
肾移植受者需要免疫抑制维持治疗以避免急性排斥反应和移植肾的丧失。大多数药物,除了belatacept,是固体口服药物,给需要肠内喂养管的患者带来困难。通过肠内喂养管给药需要考虑管的放置位置、药物配方和相容性。处理药品的职业安全也应得到重视。我们回顾了现有的文献,以确保全面纳入的证据,以指导免疫抑制治疗移植受者肠内喂养管管理。建议一个深入的框架,优先考虑患者口服免疫抑制药物,其次是静脉注射作为短期措施,只有当这是唯一可行的途径时,才给予肠内喂食管。在此提供一个实用的指南,当移植团队不得不求助于肠内喂养管给药。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical nephrology
Clinical nephrology 医学-泌尿学与肾脏学
CiteScore
2.10
自引率
9.10%
发文量
138
审稿时长
4-8 weeks
期刊介绍: Clinical Nephrology appears monthly and publishes manuscripts containing original material with emphasis on the following topics: prophylaxis, pathophysiology, immunology, diagnosis, therapy, experimental approaches and dialysis and transplantation.
期刊最新文献
Diversifying aquapheresis in critical care: An institutional experience. Dose response of PTH and FGF23 to paricalcitol in patients with end-stage renal failure on chronic intermittent hemodialysis. Primary membranous nephropathy in Singapore over the past decade and response to therapy. Renal survival in idiopathic membranous nephropathy: The impact of chronicity score and clinical predictors. Exploring factors and models to predict post-dialysis volume overload status in maintenance hemodialysis patients based on pre-dialysis parameters.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1